Works matching IS 00099236 AND DT 2023 AND VI 114 AND IP 4

Results: 26

Why is There Still Debate About Recommending DPYD‐Testing Before Fluoropyrimidine Treatment?
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 733, doi. 10.1002/cpt.3016
By:
- Cascorbi, Ingolf
Publication type:
Article
ASCPT NEWS.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 740, doi. 10.1002/cpt.3014
Publication type:
Article
In this Issue.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 731, doi. 10.1002/cpt.3013
Publication type:
Article
Highlights.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 738, doi. 10.1002/cpt.3011
Publication type:
Article
Design and Execution of Sustainable Decentralized Clinical Trials.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 802, doi. 10.1002/cpt.3009
By:
- Singh, Pritibha;
- Burden, Andrea M.;
- Natanegara, Fanni;
- Beckman, Robert A.
Publication type:
Article
Physiologically Based Pharmacokinetic Modeling and Simulation of Mavacamten Exposure with Drug–Drug Interactions from CYP Inducers and Inhibitors by CYP2C19 Phenotype.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 922, doi. 10.1002/cpt.3005
By:
- Chiang, Manting;
- Sychterz, Caroline;
- Perera, Vidya;
- Merali, Samira;
- Palmisano, Maria;
- Templeton, Ian E.;
- Gaohua, Lu
Publication type:
Article
Suboptimal Outcomes and Retreatment Rate of Patients With Crohn's Disease After Forced Discontinuation of Biologics: A Nationwide Population‐Based Study.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 914, doi. 10.1002/cpt.3003
By:
- Chen, Nai‐Yu;
- Chuang, Chiao‐Hsiung;
- Chang, Yu‐Ching;
- Kao Yang, Yea‐Huei;
- Chen, Peng‐Hsu;
- Cheng, Ching‐Lan
Publication type:
Article
Key Pharmacokinetic Parameters of 74 Pediatric Anticancer Drugs Providing Assistance in Preclinical Studies.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 904, doi. 10.1002/cpt.3002
By:
- Jamaladdin, Nora;
- Sigaud, Romain;
- Kocher, Daniela;
- Kolodziejczak, Anna S.;
- Nonnenbroich, Leo F.;
- Ecker, Jonas;
- Usta, Diren;
- Benzel, Julia;
- Peterziel, Heike;
- Pajtler, Kristian W.;
- van Tilburg, Cornelis M.;
- Oehme, Ina;
- Witt, Olaf;
- Milde, Till
Publication type:
Article
A Case for Synthetic Data in Regulatory Decision‐Making in Europe.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 795, doi. 10.1002/cpt.3001
By:
- Alloza, Clara;
- Knox, Bethany;
- Raad, Hanaya;
- Aguilà, Mireia;
- Coakley, Ciara;
- Mohrova, Zuzana;
- Boin, Élodie;
- Bénard, Marc;
- Davies, Jessica;
- Jacquot, Emmanuelle;
- Lecomte, Coralie;
- Fabre, Alban;
- Batech, Michael
Publication type:
Article
Non‐Medical Switching from Tocilizumab to Sarilumab in Rheumatoid Arthritis Patients with Low Disease Activity, an Observational Study.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 810, doi. 10.1002/cpt.2999
By:
- den Broeder, Nathan;
- den Broeder, Alfons A.;
- Verhoef, Lise M.;
- van den Hoogen, Frank H. J.;
- van der Maas, Aatke;
- van den Bemt, Bart J. F.
Publication type:
Article
Hybrid Controlled Clinical Trials Using Concurrent Registries in Amyotrophic Lateral Sclerosis: A Feasibility Study.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 883, doi. 10.1002/cpt.2994
By:
- van Eijk, Ruben P. A.;
- van den Berg, Leonard H.;
- Roes, Kit C. B.;
- Tian, Lu;
- Lai, Tze L.;
- Nelson, Lorene M.;
- Li, Chenyu;
- Scowcroft, Anna;
- Garcia‐Segovia, Jesus;
- Lu, Ying
Publication type:
Article
Modeling of Proliferating CD4 and CD8 T‐Cell Changes to Tremelimumab Exposure in Patients with Unresectable Hepatocellular Carcinoma.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 874, doi. 10.1002/cpt.2992
By:
- Song, Xuyang;
- Kelley, Robin Kate;
- Green, Michelle;
- Standifer, Nathan;
- Lim, KyoungSoo;
- Zhou, Diansong;
- Dunyak, James;
- Negro, Alejandra;
- Kurland, John F.;
- Ren, Song;
- Khan, Anis A.;
- Gibbs, Megan;
- Abou‐Alfa, Ghassan K.
Publication type:
Article
Application of Quantitative Systems Pharmacology to Pediatric Drug Safety Assessment.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 748, doi. 10.1002/cpt.2990
By:
- Samuels, Sherbet;
- Bai, Jane P. F.;
- Green, Dionna J.;
- Abulwerdi, Gelareh;
- Burckart, Gilbert J.
Publication type:
Article
Clinical Pharmacology Applications of Real‐World Data and Real‐World Evidence in Drug Development and Approval–An Industry Perspective.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 751, doi. 10.1002/cpt.2988
By:
- Zhu, Rui;
- Vora, Bianca;
- Menon, Sujatha;
- Younis, Islam;
- Dwivedi, Gaurav;
- Meng, Zhaoling;
- Datta‐Mannan, Amita;
- Manchandani, Pooja;
- Nayak, Satyaprakash;
- Tammara, Brinda K.;
- Garhyan, Parag;
- Iqbal, Shahed;
- Dagenais, Simon;
- Chanu, Pascal;
- Mukherjee, Arnab;
- Ghobadi, Cyrus
Publication type:
Article
Repurposing Artificial Intelligence Tools for Disease Modeling: Case Study of Face Recognition Deficits in Neurodegenerative Diseases.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 862, doi. 10.1002/cpt.2987
By:
- Singh, Gargi;
- Ramanathan, Murali
Publication type:
Article
Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 780, doi. 10.1002/cpt.2984
By:
- Hau, Raymond K.;
- Wright, Stephen H.;
- Cherrington, Nathan J.
Publication type:
Article
Predicting Treatment Effects of a New‐to‐Market Drug in Clinical Practice Based on Phase III Randomized Trial Results.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 853, doi. 10.1002/cpt.2983
By:
- Shin, HoJin;
- Wang, Shirley V.;
- Kim, Dae Hyun;
- Alt, Ethan;
- Mahesri, Mufaddal;
- Bessette, Lily G.;
- Schneeweiss, Sebastian;
- Najafzadeh, Mehdi
Publication type:
Article
Population Pharmacokinetics of Oral Azacitidine, and Exposure–Response Analysis in Acute Myeloid Leukemia.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 845, doi. 10.1002/cpt.2982
By:
- Gaudy, Allison;
- Laille, Eric;
- Bailey, Rochelle;
- Zhou, Simon;
- Skikne, Barry;
- Beach, C.L.
Publication type:
Article
Patterns of Prescription Medication Use during the First Trimester of Pregnancy in the United States, 1997–2018.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 836, doi. 10.1002/cpt.2981
By:
- Werler, Martha M.;
- Kerr, Stephen M.;
- Ailes, Elizabeth C.;
- Reefhuis, Jennita;
- Gilboa, Suzanne M.;
- Browne, Marilyn L.;
- Kelley, Katherine E.;
- Hernandez‐Diaz, Sonia;
- Smith‐Webb, Rashida S.;
- Garcia, Michelle Huezo;
- Mitchell, Allen A.
Publication type:
Article
Understanding Statin‐Roxadustat Drug–Drug‐Disease Interaction Using Physiologically‐Based Pharmacokinetic Modeling.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 825, doi. 10.1002/cpt.2980
By:
- Dong, Jin;
- Prieto Garcia, Luna;
- Huang, Yingbo;
- Tang, Weifeng;
- Lundahl, Anna;
- Elebring, Marie;
- Ahlström, Christine;
- Vildhede, Anna;
- Sjögren, Erik;
- Någård, Mats
Publication type:
Article
Six Years of the US Food and Drug Administration's Postmarket Active Risk Identification and Analysis System in the Sentinel Initiative: Implications for Real World Evidence Generation.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 815, doi. 10.1002/cpt.2979
By:
- Maro, Judith C.;
- Nguyen, Michael D.;
- Kolonoski, Joy;
- Schoeplein, Ryan;
- Huang, Ting‐Ying;
- Dutcher, Sarah K.;
- Dal Pan, Gerald J.;
- Ball, Robert
Publication type:
Article
Response to the FDA Decision Regarding DPYD Testing Prior to Fluoropyrimidine Chemotherapy.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 768, doi. 10.1002/cpt.2978
By:
- Hertz, Daniel L.;
- Smith, D. Max;
- Scott, Stuart A.;
- Patel, Jai N.;
- Hicks, J. Kevin
Publication type:
Article
Methotrexate Polyglutamates Exposure – Response Modeling in a Large Cohort of Rheumatoid Arthritis Patients Starting Methotrexate.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 893, doi. 10.1002/cpt.2974
By:
- Hebing, Renske C. F.;
- Bartelink, Imke H.;
- Gosselt, Helen R.;
- Heil, Sandra G.;
- de Rotte, Mauritis C. F. J.;
- de Jong, Pascal H. P.;
- Nurmohamed, Mike T.;
- de Jonge, Robert;
- Mathôt, Ron A. A.
Publication type:
Article
Interpretation of Pharmacovigilance Disproportionality Analyses.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 745, doi. 10.1002/cpt.2951
By:
- Khouri, Charles;
- Fusaroli, Michele;
- Salvo, Francesco;
- Raschi, Emanuel
Publication type:
Article
Reply to "Interpretation of Pharmacovigilance Disproportionality Analyses".
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 747, doi. 10.1002/cpt.2950
By:
- Prontskus, Viktoryia;
- Fresse, Audrey;
- Yelehe, Mélissa;
- Beurrier, Mathilde;
- Gillet, Pierre
Publication type:
Article
Issue Information.
Published in:
Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 723, doi. 10.1002/cpt.2662
Publication type:
Article